Outcomes in patients with refractory/relapsed CNS lymphoma treated in complete remission: autologous transplantation vs. CAR-T therapy.

Saved in:
Bibliographic Details
Title: Outcomes in patients with refractory/relapsed CNS lymphoma treated in complete remission: autologous transplantation vs. CAR-T therapy.
Authors: Yang F; Department of Lymphoma and Myeloma Research Center, GoBroad Hospital, Building 1, No.4 Science Park Road, Life Science Park, Changping District, Beijing, 102200, China., Liu R; Department of Lymphoma and Myeloma Research Center, GoBroad Hospital, Building 1, No.4 Science Park Road, Life Science Park, Changping District, Beijing, 102200, China., Fu Z; Department of Lymphoma and Myeloma Research Center, GoBroad Hospital, Building 1, No.4 Science Park Road, Life Science Park, Changping District, Beijing, 102200, China., Guo Y; Department of Lymphoma and Myeloma Research Center, GoBroad Hospital, Building 1, No.4 Science Park Road, Life Science Park, Changping District, Beijing, 102200, China., Ma L; Department of Lymphoma and Myeloma Research Center, GoBroad Hospital, Building 1, No.4 Science Park Road, Life Science Park, Changping District, Beijing, 102200, China., Cao M; Department of Lymphoma and Myeloma Research Center, GoBroad Hospital, Building 1, No.4 Science Park Road, Life Science Park, Changping District, Beijing, 102200, China., Deng B; Cytology Laboratory, Beijing GoBroad Boren Hospital, Jitong East Road No.6, Fengtai District, Beijing, 100070, China., Wu H; Department of Biostatistics, GoBroad Research Center, Leeza SOHO South Tower, Fengtai District, Beijing, 100073, China., Chen C; Department of Biostatistics, GoBroad Research Center, Leeza SOHO South Tower, Fengtai District, Beijing, 100073, China., Ke X; Department of Lymphoma and Myeloma Research Center, GoBroad Hospital, Building 1, No.4 Science Park Road, Life Science Park, Changping District, Beijing, 102200, China., Hu K; Department of Lymphoma and Myeloma Research Center, GoBroad Hospital, Building 1, No.4 Science Park Road, Life Science Park, Changping District, Beijing, 102200, China. huk@gobroadhealthcare.com.
Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 Mar 24; Vol. 75 (4). Date of Electronic Publication: 2026 Mar 24.
Publication Type: Journal Article; Observational Study; Comparative Study
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-0851
DOI:10.1007/s00262-026-04334-x